Kellen K. Petersen
Tracked across 1 events · 6 articles · First seen Feb 19, 2026 · Last active Feb 23, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Kellen K. Petersen is the lead author of the study, explaining how the p-tau217 protein acts as a 'clock' to predict symptom onset and its potential for clinical trials.
Feb 19, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Kellen K. Petersen live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard